Clinical Trials

Treatment for Gonorrhea

Posted on 1/15/2020
This research study is being performed to learn more about gonorrhea and if the study drug called gepotidacin is safe and effective for patients with active gonorrhea infections.  Gepotidacin is experimental, which means it has not been approved by the FDA for use in people with gonorrhea infections.  The study will compare the study drug, gepotidacin with ceftriaxone plus oral azithromycin which is an approved treatment.  

The study duration is about 21 days and there will be 3 clinic visits.  Most visits will require about 2-3 hours.

You may qualify to screen for this study if you:
  • are male or female at least 12 years of age and older
  • have a clinical suspicion of a urogenital gonococcal infection with possible symptoms of yellow discharge, pain or burning

There will be no charge for participating in the study.  All study medication, study procedures, materials and study specific visits will be provided at no charge to you or your insurance company.  

If you qualify and decide to participate you will be compensated for your time and travel while participating in the study.  You will receive up to a total of $228 if you complete all study visits.

Call our office for more information - (903) 238-8854

What Our Research Patients are Saying
Everyone at DCOL Research is friendly and helpful. They all have a great sense of humor, which really helps you relax.  I have participated in several studies with them and the research coordinator I see is awesome. She makes you feel that your health is her top priority.  The research doctor is really good too and if you start having problems during the study he will take care of you. This research clinic is like a family, and once you participate in a study, you are just part of the family.     R. O.

Contact Form

DCOL of Longview